Critical Review: DarioHealth (NASDAQ:DRIO) and IRadimed (NASDAQ:IRMD)


IRadimed (NASDAQ:IRMD – Get Rating) and DarioHealth (NASDAQ:DRIO – Get Rating) are both small medical companies, but which is the better investment? We’ll contrast the two companies based on the strength of their risk, analyst recommendations, profitability, institutional ownership, valuation, earnings, and dividends.

Insider and Institutional Property

39.9% of IRadimed shares are held by institutional investors. In comparison, 49.0% of DarioHealth shares are held by institutional investors. 43.7% of IRadimed shares are held by insiders. In comparison, 14.1% of DarioHealth stock is held by insiders. Strong institutional ownership is an indication that hedge funds, endowments, and large wealth managers believe a company is poised for long-term growth.

Volatility & Risk

IRadimed has a beta of 0.92, meaning its stock price is 8% less volatile than the S&P 500. In comparison, DarioHealth has a beta of 1.3, meaning its stock price is 30% more volatile than the S&P 500

Analyst Recommendations

This is a breakdown of the most recent ratings and price targets for IRadimed and DarioHealth as provided by MarketBeat.com.

sell reviews keep ratings Buy reviews Strong buy recommendations rating score
irradiated 0 0 1 0 3.00
Dario health 0 0 3 0 3.00

IRadimed currently has a consensus price target of $42.00, indicating a potential upside of 20.34%. DarioHealth has a consensus price target of $17.44, indicating a potential upside of 158.33%. Given DarioHealth’s higher potential upside potential, analysts clearly believe that DarioHealth is cheaper than IRadimed.

profitability

This table compares the net margins, return on equity and return on assets of IRadimed and DarioHealth.

net margins return on equity return on investment
irradiated 23.22% 15.26% 13.20%
Dario health -311.13% -73.61% -65.27%

evaluation and result

This table compares the revenue, earnings per share (EPS) and valuation of IRadimed and DarioHealth.

gross receipts price/sales ratio net income earnings per share price-earnings ratio
irradiated $41.81 million 10.49 $9.32 million $0.83 42.05
Dario health $20.51 million 7.52 -$76.76 million ($4.00) -1.69

IRadimed has higher sales and earnings than DarioHealth. DarioHealth is trading at a lower price-to-earnings ratio than IRadimed, suggesting it’s the cheaper of the two stocks at the moment.

summary

IRadimed beats DarioHealth on 9 of the 13 factors compared between the two stocks.

IRadimed company profile (get rating)

IRADIMED CORPORATION designs, manufactures, markets and sells magnetic resonance imaging (MRI) compatible medical devices and related accessories and services in the United States and internationally. It offers a MRidium MRI-compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. The company also offers non-magnetic IV poles, wireless remote displays/controllers, sidecar pump modules, dose error reduction systems and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities and ambulatory imaging centers. The company sells its products through direct sales representatives, regional sales managers, clinical support representatives and independent distributors. IRADIMED CORPORATION was founded in 1992 and is headquartered in Winter Springs, Florida.

DarioHealth Company Profile (get rating)

DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia and New Zealand. The Company offers Dario’s metabolic solutions to address metabolic health needs such as diabetes, hypertension and weight management; Dario Musculoskeletal, which helps prevent and treat the most common MSK disorders; Dario’s behavioral health solution that optimizes access to evidence-based care; chronic disease management solutions; DarioEngage, a proprietary care management platform; and device-specific disposable test strip cartridges, lancets, and blood glucose monitoring systems. It also offers smart blood glucose meters; blood pressure cuff with bluetooth connection; digital scales; biofeedback sensor devices; and diabetes management programs, including lifestyle changes, healthy eating, advanced tracking and live coaching. The company was formerly LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was founded in 2011 and is based in New York, New York.



Receive News & Reviews for IRadimed Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for IRadimed and related companies with MarketBeat.com’s FREE daily email newsletter.

Comments are closed.